Cigna GLP-1 Coverage for Weight Loss (2026)

If you searched “does Cigna cover GLP-1s” recently, you probably ran into an alarming headline from June 2026 saying Cigna dropped coverage of GLP-1 obesity medications. Take a breath. That story is real, but it is almost universally misread, and it very likely does not apply to you. Here is what actually happened, what Cigna coverage really looks like as of August 2026, and exactly how to find out where your own plan stands.

First, the headline that confused everyone

On June 2, 2026, Reuters reported that Cigna was dropping coverage of GLP-1 medications for obesity. What most of the shares and summaries left out is the scope: that change applied only to Cigna’s own internal employee health plan, the benefits Cigna offers its own workforce, effective July 1, 2026.

Client and employer plans, meaning the Cigna plan you might have through your job, were not affected by that decision, and even on the employee plan, GLP-1 medications for type 2 diabetes remained covered. If your insurance card says Cigna, that headline did not remove your benefit. Your coverage is still determined the same way it was before: by what your employer chose to include in the plan.

It is fair to read the move as a signal of how one large company weighed the cost of these medications for its own employees. It is not accurate to read it as “Cigna no longer covers GLP-1s.” Those are different things, and the difference matters a great deal if you are trying to figure out your own next step.

The short answer for your plan

As of August 2026, most Cigna commercial plans treat weight loss medications as an optional benefit. Coverage for GLP-1s prescribed for weight management exists when your employer specifically elected to buy that coverage. So the real question is not “does Cigna cover GLP-1s,” it is “did my employer buy that coverage.” Some did. Many did not.

GLP-1 medications prescribed for type 2 diabetes are a separate, generally covered category, with their own criteria. This page is about coverage for weight management.

How Cigna handles weight loss GLP-1s

Where the benefit exists, Cigna does not simply hand out approvals. Prior authorization applies, and the criteria follow a familiar pattern.

One feature sets Cigna apart from most carriers. Its pharmacy benefits arm, Evernorth, runs a GLP-1 cost-containment program called EncircleRx, which Evernorth reported covers more than nine million enrolled lives. In May 2025, Evernorth announced a benefit option that limits member out-of-pocket costs to no more than $200 per month on both leading brand-name GLP-1 medications for weight management, with those amounts counting toward the deductible, for plan sponsors that adopt it. If your employer participates, that cap can make the covered path far more affordable than a standard coinsurance arrangement.

The criteria above reflect Cigna’s published national formulary coverage policy as of mid-2026 and vary by plan and benefit design. Some published benefit designs use different thresholds, for example a BMI of 32 or higher, or 27 or higher with two weight-related conditions, under one EncircleRx benefit policy. Your plan documents are the only version that counts for you.

What changed in 2025 and 2026

May 21, 2025. Evernorth announced a benefit option, built on its EncircleRx program, that limits member out-of-pocket costs for the two leading brand-name GLP-1 weight management medications to no more than $200 per month, for plan sponsors that adopt it.

June 2, 2026. Reuters reported that Cigna would drop weight loss GLP-1 coverage on its own internal employee plan. The story spread widely without the scope attached.

July 1, 2026. That internal employee plan change took effect. Client and employer plans were not affected.

The pattern to take away: the benefit design for Cigna members has been stable, but the category as a whole moves quickly, and employer decisions get revisited every plan year. A benefit you have this year is worth confirming again at open enrollment.

How to check your own plan in ten minutes

You do not need to interpret headlines, and you do not need to wait for a denial letter. Three routes, fastest first:

Ask your benefits administrator at work. The single decisive fact is whether your employer elected weight loss medication coverage. HR or your benefits portal can answer that directly. While you are at it, ask whether the plan participates in EncircleRx or any GLP-1 cost cap program.

Call member services. Use the number on your card and ask three questions. Does my plan include coverage for weight loss medications? If so, which GLP-1 medications are on the formulary and what does prior authorization require? And does my plan participate in a program that caps my monthly out-of-pocket cost?

Check your prescription drug list. Log in to your member portal and search the drug list for semaglutide or tirzepatide. Pay attention to the indication notes; a listing under diabetes coverage does not mean weight management is covered.

If the benefit exists, your next step is the paperwork. Our guide to GLP-1 prior authorization walks through the documentation that makes approvals succeed, including the BMI record and lifestyle-effort notes that Cigna’s criteria ask for. Most first denials are documentation gaps rather than final answers.

If your plan says no

Plenty of people with Cigna cards land here, through no fault of their own. What you do next depends on why the answer was no.

The denial was about criteria or documentation. This is often fixable. A documented BMI from a recent visit, weight-related conditions noted explicitly in your chart, and at least three months of recorded lifestyle efforts turn many denials into approvals on appeal. Start with our guide on what to do when insurance denies your GLP-1.

Your employer did not buy the benefit. An appeal generally cannot override a categorical exclusion, because the medication simply is not a covered benefit on your plan. You can ask HR whether the benefit or the EncircleRx cap is under consideration for the next plan year, and it may be worth asking your provider whether any covered indication applies to you. Beyond that, the realistic path is cash pay.

Paying cash for a brand-name GLP-1 commonly runs roughly $900 to $1,500 per month at the pharmacy, according to third-party pricing trackers, which is not sustainable for most people. An all-inclusive compounded telehealth program is the lower-cost cash-pay route: one monthly price covering the medication, lab work, provider care, and coaching, with no insurance involved at all. Compounded medications are not FDA-approved and are not the same as brand-name products, which a provider will explain before anything is prescribed. If that trade-off makes sense for your situation, compounded GLP-1 without insurance explains exactly how it works, and the full insurance coverage overview can help you weigh the options side by side.

You do not need a denial letter or any insurance paperwork to start. You complete a free online assessment, an independent, licensed provider reviews your health history, and if a GLP-1 program is medically appropriate, your prescription is prepared by a US-based, state-licensed compounding pharmacy and shipped to you. Not everyone qualifies, and the provider makes that decision.

Sources

• Reuters reporting, June 2, 2026, on Cigna dropping GLP-1 obesity medication coverage for its own employees only, effective July 1, 2026, with client plans unaffected and diabetes coverage continuing, as carried by Becker’s. Accessed August 3, 2026. (beckershospitalreview.com)
• Evernorth announcement, May 21, 2025, of a benefit option limiting member cost for the leading brand-name GLP-1 weight management medications to no more than $200 per month, built on the EncircleRx program covering more than nine million enrolled lives. Accessed August 3, 2026. (evernorth.com)
• Cigna national formulary coverage position policy for weight loss GLP-1 agonist prior authorization, including BMI, lifestyle documentation, and renewal weight loss criteria, and a separate EncircleRx benefit policy with different thresholds. Accessed August 3, 2026. (static.cigna.com)
• Third-party coverage tracking of Cigna formulary positions and prior authorization criteria for weight loss GLP-1s. Accessed August 3, 2026. (findhonestcare.com)

Coverage information on this page is current as of August 3, 2026, is general and educational, and changes frequently. It does not represent the terms of your specific plan. Confirm current benefits, formulary status, and prior authorization requirements directly with Cigna member services or your plan administrator.